We are live on
!
Find out more
Evolent Health
EVH
EVH
215 hedge funds and large institutions have $482M invested in Evolent Health in 2025 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 81 increasing their positions, 65 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
215% more call options, than puts
Call options by funds: $3.04M | Put options by funds: $966K
25% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 65
7.45% less ownership
Funds ownership: 115.45% → 108% (-7.4%)
10% less funds holding
Funds holding: 240 → 215 (-25)
31% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 54
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
58% less capital invested
Capital invested by funds: $1.15B → $482M (-$666M)
Holders
215
Holders Change
-25
Holders Change %
-10.42%
% of All Funds
2.61%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.02%
New
37
Increased
81
Reduced
65
Closed
54
Calls
$3.04M
Puts
$966K
Net Calls
+$2.08M
Net Calls Change
+$802K
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$15M |
| 2 |
D.E. Shaw & Co
New York
|
+$14.1M |
| 3 |
Jane Street
New York
|
+$8.4M |
| 4 |
TC
Tejara Capital
London,
United Kingdom
|
+$7.4M |
| 5 |
Morgan Stanley
New York
|
+$7.22M |
